COUR Pharmaceuticals Development Co Inc.

Marcus Bowie signed COUR Pharmaceuticals Development Co Inc.'s 2024 Form 5500 as plan administrator.

• Marcus Bowie — Plan Administrator — Form 5500 signer

Signer names are public record from the Form 5500 e-signature.

COUR Pharmaceuticals Development Co Inc.'s EIN is 46-1881230.

Download the official 2024 Form 5500 (PDF) for COUR Pharmaceuticals Development Co Inc. from the U.S. Department of Labor's EFAST2 system.

COUR Pharmaceuticals Development Co Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, automatic enrollment, a default investment (QDIA).